Lactose (India)

Lactose (India) Net Margin

The Net Profit Margin of Lactose (India) (524202.BO) as of Nov 13, 2026 is 3.71 %. In the previous year, Net Profit Margin was 4.44 % — a change of -16.25% (lower).

Net Margin

3.71 %

YoY

-16.25%

Last updated:

Net Profit Margin of Lactose (India) is 2026 3.71 % . Net Profit Margin of Lactose (India) was 2025 4.44 % . It decreases by -16.25% lower compared to the previous year.

For Lactose (India), the net margin of 3.7% is down versus 5.3% a few years ago.

The Lactose (India) Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
1.77 INR
Jan 1, 2020
0.18 INR
Jan 1, 2021
-7.09 INR
Jan 1, 2022
5.34 INR
Jan 1, 2023
1.84 INR
Jan 1, 2024
5.96 INR
Jan 1, 2025
4.44 INR
Jan 1, 2026
3.71 INR
The Lactose (India) Net Margin history
YEARNet MarginYoY
3.71 %-16.25%
4.44 %-25.59%
5.96 %+224.49%
1.84 %-65.58%
5.34 %-175.32%
-7.09 %-4,035.66%
0.18 %-89.85%
1.77 %-141.53%
-4.27 %-154.90%
7.78 %-4.38%
8.13 %+285.81%
2.11 %+1,689.76%
0.12 %+468.93%
0.02 %+19.31%
0.02 %-38.73%
0.03 %+40.54%
0.02 %+770.62%
0.00+30.88%
0.00-58.18%
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lactose (India) Stock analysis

What does Lactose (India) do? Lactose India Ltd. generates revenue through the manufacturing of pharmaceutical products, primarily lactose monohydrate and disaccharide lactulose. The company produces dry granulated, film and lacquer coated tablets, and offers prebiotic-galacto-oligosaccharides (GOS) for applications in dairy, beverages, bakery, infant nutrition, clinical nutrition, children's products, and geriatric nutrition. Its plant in Vadodara, Gujarat, has an installed capacity of 180 metric tons annually for pharma color coatings. The firm serves segments including liquid dosage forms, solid dosage forms, excipients, and active pharmaceutical ingredients. The company's main products are lactose monohydrate, lactulose, and GOS, which are sold to pharmaceutical manufacturers and food industry players. Lactose monohydrate is used as an excipient in solid dosage forms, while lactulose serves as an active pharmaceutical ingredient. GOS is marketed for use in infant nutrition, clinical nutrition, and other food applications. The plant in Vadodara supports production of these products alongside pharma color coatings. Lactose India Ltd. targets pharmaceutical companies requiring excipients and active ingredients, as well as food and beverage manufacturers seeking prebiotic additives. The firm's product range includes lactose monohydrate for solid dosage forms, lactulose for active pharmaceutical ingredients, and GOS for nutritional applications across multiple consumer segments. Its production capabilities support the growing demand for pharmaceutical and functional food ingredients in India. Lactose (India) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lactose (India) stock

Net Profit Margin of Lactose (India) is 3.71 % in 2026.

Net Profit Margin of Lactose (India) changed from 4.44 % to 3.71 %, representing a -16.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Lactose (India) since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Lactose (India) with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Lactose (India)

All Key Metrics — Lactose (India)